John A. Martignetti

Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome.

The Krüppel traffic report: cooperative signals direct KLF8 nuclear transport.

Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression.

IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer.

Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer.

Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis.

Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA.

Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinoma.

The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.

Porokeratotic Adnexal Ostial Nevus-Report of a Case With Unusual Clinical and Histologic Features.

Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.

Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.

Applying Precision Medicine to Ovarian Cancer: Proof-of-Principle for a "Molecular Second Look".

Protein-losing enteropathy and joint contractures caused by a novel homozygous ANTXR2 mutation.

Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy.